Evaluation of the need for simultaneous cholecystectomy in patients with thalassemia major under splenectomy
Authors
-
Ali Asghar Darzi
- Dept. of Surgery, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
https://orcid.org/0000-0001-5653-8633
-
Sekineh Kamali Ahangar
- Clinical Research Development Center, Shahid Beheshti Hospital, Babol University of Medical Sciences, Babol, Iran.
https://orcid.org/0000-0003-0906-4804
- Hemmat Gholinia - Clinical Research Development Center, Shahid Beheshti Hospital, Babol University of Medical Sciences, Babol, Iran.
-
Asadollah ZeinolAbedini
- Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
https://orcid.org/0000-0003-1080-7441
DOI:
https://doi.org/10.22100/jkh.v19i2.3157Keywords:
Cholecystectomy, Thalassemia major, Splenectomy, Ultrasound, Gallstones, SurgeryAbstract
Introduction: This study aims to investigate the necessity of simultaneous cholecystectomy in thalassemia major patients undergoing splenectomy, in light of reports regarding the prevalence of gallstones in these patients and the overall incidence of the disease in Mazandaran.
Methods: This study was conducted on all 247 patients with beta-thalassemia major, who underwent splenectomy surgery during 2010-2020 for any indication in medical centers affiliated to Babol University of Medical Sciences (without a history of this procedure). Their percentage was determined and a decision was made regarding simultaneous surgery of cholecystectomy and splenectomy. Sampling was done by census method and all cases were reviewed and patients were followed up by phone and the necessary information was extracted and recorded in the checklist. Data were described using SPSS 22 software and analyzed at a significance level of 0.05.
Results: A total of 247 patients with an average age of 20.13 ± 3.98 years (minimum age 10 and maximum age 29) were included in the study. The frequency of simultaneous cholecystectomy was reported in 33 cases (13.4%). Out of 214 patients who did not need simultaneous cholecystectomy (57.9%), 183 patients underwent cholecystectomy after splenectomy (85.5%).In 28 people (11.3 percent) had normal ultrasound and 3 people (1.3 percent) died. The prevalence of gallstones was reported as 87.4 percent. It is The average time for cholecystectomy compared to splenectomy in 183 patients who underwent cholecystectomy was 13.41±6.94 months (minimum time interval 3 and maximum 28 months) and in the examination of ultrasound findings, 219 patients (88.7%) had stones. They had a gall bladder and normal ultrasound was reported in 28 people (11.3%).
Conclusion: The study results indicate a high prevalence of gallstones in patients with thalassemia major. Therefore, it suggests that simultaneous cholecystectomy and splenectomy should be considered, even in asymptomatic cases.
References
Miri-Aliabad G, Fadaee M, Khajeh A, Naderi M. Marital status and fertility in adult Iranian patients with β-Thalassemia Major. Indian Journal of Hematology and Blood Transfusion 2016;32:110-3. doi: 10.1007/s12288-015-0510-9
Sandler A, Winkel G, Kimura K, Soper R. The role of prophylactic cholecystectomy during splenectomy in children with hereditary spherocytosis. Journal of Pediatric Surgery 1999;34:1077-8. doi: 10.1016/s0022-3468(99)90569-9
Shahramian I, Behzadmehr R, Afshari M, Allahdadi A, Delaramnasab M, Bazi A. Cholelithiasis in Thalassemia major patients: A report from the South-East of Iran. International Journal of Hematology-Oncology and Stem Cell Research 2018;12:117-22.
Darzi AA, Kamali S, Khakzad M. Influence of splenectomy on immunoglobulins and complement components in major thalassemia. Caspian Journal of Internal Medicine 2015;6:30.
Abdullah UY, Jassim HM, Baig AA, Khorsheed RM, AL-KHAYAT A, Sulong AF, et al. Gallstones in patients with inherited hemolytic diseases. International Journal of Pharmacy and Pharmaceutical Sciences 2015;7:9-15. doi: 10.22159/ajpcr.2019.v12i9.33694
Goldfarb A, Grisaru D, Gimmon Z, Okon E, Lebensart P, Rachmilewitz E. High incidence of cholelithiasis in older patients with homozygous beta-thalassemia. Acta Haematologica 1990;83:120-2. doi: 10.1159/000205186
Taher A, Isma'eel H, Cappellini MD. Thalassemia intermedia: revisited. Blood Cells, Molecules, and Diseases 2006;37:12-20. doi: 10.1016/j.bcmd.2006.04.005
Merchant RH, Shah AR, Ahmad J, Karnik A, Rai N. Post splenectomy outcome in β-thalassemia. The Indian Journal of Pediatrics 2015;82:1097-100. doi: 10.1007/s12098-015-1792-5
Al-Salem AH. Should cholecystectomy be performed concomitantly with splenectomy in children with sickle-cell disease? Pediatric Surgery International 2003;19:71-4. doi: 10.1007/s00383-002-0804-5
McAneny D, Godek CP, Scott TE, LaMorte WW, Beazley RM. Risks of synchronous gastrointestinal or biliary surgery with splenectomy for hematologic disease-discussion. Arch Surg 1996;131:372-6. doi: 10.1001/archsurg.1996.01430160030004
Khavari M, Hamidi A, Haghpanah S, Bagheri MH, Bardestani M, Hantooshzadeh R, et al. Frequency of cholelithiasis in patients with Beta-thalassemia intermedia with and without hydroxyurea. Iranian Red Crescent Medical Journal 2014;16. doi: 10.5812/ircmj.18712
Lotfi M, Keramati P, Assdsangabi R, Nabavizadeh SA, Karimi M. Ultrasonographic assessment of the prevalence of cholelithiasis and biliary sludge in beta-thalassemia patients in Iran. Medical Science Monitor 2009;15:CR398-402.
Papakonstantinou O, Drakonaki EE, Maris T, Vasiliadou A, Papadakis A, Gourtsoyiannis N. MR imaging of spleen in beta-thalassemia major. Abdominal Imaging 2015;40:2777-82. doi: 10.1007/s00261-015-0461-5
Telfer P, Coen PG, Christou S, Hadjigavriel M, Kolnakou A, Pangalou E, et al. Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004. Haematologica 2006;91:1187-92.
Rafsanjani KA, Mafi N, Tafreshi RI. Complications of β-thalassemia intermedia in Iran during 1996-2010 (single-center study). Pediatric Hematology and Oncology 2011;28:497-508. doi: 10.3109/08880018.2011.572144
Poddar U. Gallstone disease in children. Indian Pediatr 2010;47:945-53. doi: 10.1007/s13312-010-0159-2.
Origa R, Galanello R, Perseu L, Tavazzi D, Domenica Cappellini M, Terenzani L, et al. Cholelithiasis in thalassemia major. Eur J Haematol 2009;82:22-5. doi: 10.1111/j.1600-0609.2008.01162.x
Premawardhena A, Fernando R, Kumarage S, Nishad N, Goonatilleke D, Silva I, et al. Place for elective cholecystectomy for patients with severe thalassaemia: a retrospective case control study. BMC Res Notes 2019;12:245. doi: 10.1186/s13104-019-4285-1
Dewey KW, Grossman H, Canale VC. Cholelithiasis in thalassemia major. Radiology 1970;96:385-8. doi: 10.1148/96.2.385
Âbdi R, Kosaryan SAS, Kosaryan M. The incidence of cholelithiasis in thalassemic patients of Sari in 1995. Journal of Mazandaran University of Medical Sciences 2000;10:44-7.
Schizas D, Katsaros I, Karatza E, Kykalos S, Spartalis E, Tsourouflis G, et al. Concomitant laparoscopic splenectomy and cholecystectomy: A systematic review of the literature. J Laparoendosc Adv Surg Tech A 2020;30:730-6. doi: 10.1089/lap.2020.0004
el-Nawawy A, Kassem AS, Eissa M, Abdel-Fattah M, Safwat M. Gall bladder sludge and stones in multitransfused Egyptian thalassaemic patients. East Mediterr Health J 2001;7:635-41.
Darzi AA, Tamaddoni A, Ramezani M, Ramezani L, Gharghabi F, Soleymanpour N. Comparison of need of transfusion and adverse effects before and after splenectomy in beta-thalassemic patients. Journal of Babol University of Medical Sciences 2012;14:83-9.
Feretis C, Legakis N, Apostolidis N, Katergiannakis V, Philippakis M. Prophylactic cholecystectomy during splenectomy for beta thalassemia homozygous in Greece. Surgery, Gynecology & Obstetrics 1985;160:9-12.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
